Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Study Information
Alliance Study ID: CALGB-170601
NCT Study ID (ClinicalTrials.gov): NCT00489411
Disease or Cancer Type: Other Cancer
Alliance Study Chair: Ellen L. Smith, PhD, ARNP, AOCN
Status: COMPLETED
Study Description
RATIONALE: Duloxetine may lessen peripheral neuropathy caused by chemotherapy. It is not yet known whether duloxetine is more effective than a placebo in treating peripheral neuropathy caused by chemotherapy.
PURPOSE: This randomized phase III trial is studying duloxetine to see how well it works compared with a placebo in treating peripheral neuropathy caused by chemotherapy in patients with cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information